$ARMK Cashflow Statement | Understand Stock

$ARMK

$55.21 +$0.82 (1.5%) Live

$ARMK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Oct 3, 2025	FY2024 12 months to Sep 27, 2024	FY2023 12 months to Sep 29, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Oct 1, 2021
Cash flows from operating activities of Continuing Operations:
Net income (loss)
Net income from Continuing Operations
Adjustments to reconcile Net income from Continuing Operations to Net cash provided by operating activities of Continuing Operations:
Depreciation and amortization
Asset write-downs
Gain on equity investments, net (see Note 1)
Loss on defined benefit pension plan termination
Reduction of contingent consideration liability
Loss (Gain) on equity investments, net (see Note 1)
Deferred income taxes
Share-based compensation expense
Net gain on sale of Healthcare Technologies

Changes in operating assets and liabilities:
Receivables, net
Inventories
Prepayments and other current assets
Accounts payable
Accrued expenses
Payments made to clients on contracts
Changes in other noncurrent liabilities
Changes in other assets
Other operating activities
Net cash provided by operating activities
Net cash provided by operating activities of Continuing Operations
Cash flows from investing activities of Continuing Operations:
Purchases of property and equipment and other
Disposals of property and equipment
Proceeds from divestitures
Purchases of marketable securities
Proceeds from marketable securities
Acquisition of certain businesses, net of cash acquired
Proceeds from governmental agencies related to property and equipment
Acquisition of certain equity investments
Other investing activities
Net cash provided by (used in) investing activities
Net cash (used in) provided by investing activities of Continuing Operations

Cash flows from financing activities of Continuing Operations:
Proceeds from long-term borrowings
Payments of long-term borrowings
Net change in funding under the Receivables Facility
Payments of dividends
Distribution from Vestis
Proceeds from issuance of common stock
Repurchase of common stock
Payments for contingent considerations
Other financing activities
Net cash provided by (used in) financing activities
Net cash (used in) provided by financing activities of Continuing Operations
Discontinued Operations:
Net cash provided by operating activities
Net cash used in investing activities
Net cash provided by financing activities
Net cash provided by Discontinued Operations
Effect of foreign exchange rates on cash and cash equivalents and restricted cash
(Decrease) increase in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents and restricted cash, end of period
Cash and cash equivalents in current assets of discontinued operations

Comments